Falling is one of the most critical outcomes of loss of consciousness during triage in emergency department (ED). It is an important sign requires an immediate medical intervention. This paper presents a computer vision-based fall detection model in ED. In this study, we hypothesis that the proposed vision-based triage fall detection model provides accuracy equal to traditional triage system (TTS) conducted by the nursing team. Thus, to build the proposed model, we use MoveNet, a pose estimation model that can identify joints related to falls, consisting of 17 key points. To test the hypothesis, we conducted two experiments: In the deep learning (DL) model we used the complete feature consisting of 17 keypoints which was passed to the triage fall detection model and was built using Artificial Neural Network (ANN). In the second model we use dimensionality reduction Feature-Reduction for Fall model (FRF), Random Forest (RF) feature selection analysis to filter the key points triage fall classifier. We tested the performance of the two models using a dataset consisting of many images for real-world scenarios classified into two classes: Fall and Not fall. We split the dataset into 80% for training and 20% for validation. The models in these experiments were trained to obtain the results and compare them with the reference model. To test the effectiveness of the model, a t-test was performed to evaluate the null hypothesis for both experiments. The results show FRF outperforms DL model, and FRF has same accuracy of TTS.

The integration of Big Earth Data and Artificial Intelligence (AI) has revolutionized geological and mineral mapping by delivering enhanced accuracy, efficiency, and scalability in analyzing large-scale remote sensing datasets. This study appraisals the application of advanced AI techniques, including machine learning and deep learning models such as Convolutional Neural Networks (CNNs), to multispectral and hyperspectral data for the identification and classification of geological formations and mineral deposits. The manuscript provides a critical analysis of AI’s capabilities, emphasizing its current significance and potential as demonstrated by organizations like NASA in managing complex geospatial datasets. A detailed examination of selected AI methodologies, criteria for case selection, and ethical and social impacts enriches the discussion, addressing gaps in the responsible application of AI in geosciences. The findings highlight notable improvements in detecting complex spatial patterns and subtle spectral signatures, advancing the generation of precise geological maps. Quantitative analyses compare AI-driven approaches with traditional techniques, underscoring their superiority in performance metrics such as accuracy and computational efficiency. The study also proposes solutions to challenges such as data quality, model transparency, and computational demands. By integrating enhanced visual aids and practical case studies, the research underscores its innovations in algorithmic breakthroughs and geospatial data integration. These contributions advance the growing body of knowledge in Big Earth Data and geosciences, setting a foundation for responsible, equitable, and impactful future applications of AI in geological and mineral mapping.

The fast-growing field of nanotheranostics is revolutionizing cancer treatment by allowing for precise diagnosis and targeted therapy at the cellular and molecular levels. These nanoscale platforms provide considerable benefits in oncology, including improved disease and therapy specificity, lower systemic toxicity, and real-time monitoring of therapeutic outcomes. However, nanoparticles' complicated interactions with biological systems, notably the immune system, present significant obstacles for clinical translation. While certain nanoparticles can elicit favorable anti-tumor immune responses, others cause immunotoxicity, including complement activation-related pseudoallergy (CARPA), cytokine storms, chronic inflammation, and organ damage. Traditional toxicity evaluation approaches are frequently time-consuming, expensive, and insufficient to capture these intricate nanoparticle-biological interactions. Artificial intelligence (AI) and machine learning (ML) have emerged as transformational solutions to these problems. This paper summarizes current achievements in nanotheranostics for cancer, delves into the causes of nanoparticle-induced immunotoxicity, and demonstrates how AI/ML may help anticipate and create safer nanoparticles. Integrating AI/ML with modern computational approaches allows for the detection of potentially dangerous nanoparticle qualities, guides the optimization of physicochemical features, and speeds up the development of immune-compatible nanotheranostics suited to individual patients. The combination of nanotechnology with AI/ML has the potential to completely realize the therapeutic promise of nanotheranostics while assuring patient safety in the age of precision medicine.